SRL
EDSA icon

Scientech Research LLC’s Edesa Biotech EDSA Stock Holding History

Scientech Research LLC’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,534
Closed -$160K – 325
2026
Q1 		$160K Buy
+30,534
New +$91.6K 0.13% 282

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Scientech Research LLC's EDSA Position: Q2 2026 in Review

Scientech Research LLC sold out of Edesa Biotech (EDSA) in Q2 2026, closing a stake of 30,534 shares — an estimated $160K sold.

Scientech Research LLC first reported a position in EDSA in Q1 2026 and held it in 1 quarter. The position peaked at $160K in Q1 2026. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • Scientech Research LLC reported no remaining Edesa Biotech position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 30,534 Edesa Biotech shares in Q2 2026, an estimated $160K.
  • Scientech Research LLC first reported a position in Edesa Biotech in Q1 2026 and held it in 1 quarter.
  • Scientech Research LLC's Edesa Biotech position peaked at $160K in Q1 2026.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.